Literature DB >> 608497

Comparative studies on the cell wall composition of some anaerobic coryneforms of varying lympho-reticular stimulatory activity.

C Adlam, D E Reid.   

Abstract

Anaerobic diphtheroids possessing lympho-reticular stimulatory properties may differ considerably in their peptidoglycan composition. Spleen weight-increasing activity of strains directly parallels their antitumour properties. P. granulosum strains, inactive in assays for lympho-reticular stimulation, appear to have a higher cell wall alanine content than most of the P. acnes and P. avidum strains tested. Two P. acnes strains, however, had equivalently high alanine ratios and were stimulatory. The presence of galactose does not appear to be required for activity since P. acnes II strains which lack this sugar can be fully stimulatory. The existence of the species P. lymphophilum (Torrey) is further supported by the finding of two more serologically identical strains which do not cross react serologically with the other species in the group. These organisms are fully stimulatory but have lysine rather than DAP as their cell wall diamino acid.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 608497

Source DB:  PubMed          Journal:  Dev Biol Stand        ISSN: 0301-5149


  3 in total

Review 1.  Clinical and Biological Features of Cutibacterium (Formerly Propionibacterium) avidum, an Underrecognized Microorganism.

Authors:  Stéphane Corvec
Journal:  Clin Microbiol Rev       Date:  2018-05-30       Impact factor: 26.132

2.  The correlation of susceptibility of different Propionibacterium strains to macrophage killing and antitumor activity.

Authors:  W Roszkowski; H L Ko; K Roszkowski; S Szmigielski; J Jeljaszewicz; G Pulverer
Journal:  Med Microbiol Immunol       Date:  1980       Impact factor: 3.402

3.  Comparative study on the immunostimulatory potency of different Propionibacterium strains.

Authors:  H L Ko; W Roszkowski; J Jeljaszewicz; G Pulverer
Journal:  Med Microbiol Immunol       Date:  1981       Impact factor: 3.402

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.